|Bid||37.70 x 900|
|Ask||37.89 x 1800|
|Day's Range||37.29 - 37.88|
|52 Week Range||30.01 - 42.99|
|Beta (5Y Monthly)||0.36|
|PE Ratio (TTM)||11.54|
|Earnings Date||Jun 16, 2021 - Jun 21, 2021|
|Forward Dividend & Yield||0.72 (2.01%)|
|Ex-Dividend Date||May 13, 2021|
|1y Target Est||35.96|
The Kroger Co. (NYSE: KR) today announced notable progress and new initiatives – including the launch of its Small Business Resource Guide – as part of its Framework for Action: Diversity, Equity & Inclusion plan, featuring steps developed in collaboration with associates and leaders to accelerate and promote greater change in the workplace and in the communities the organization serves.
Kroger Health, the healthcare division of The Kroger Co. (NYSE: KR), today announced the launch of Abbott's BinaxNOW™ COVID-19 Antigen Self Test, an over-the-counter SARS-CoV-2 rapid antigen test that has received FDA Emergency Use Authorization for self-testing without the need for a prescription from a healthcare professional. The test allows individuals to receive results within 15 minutes, in the comfort of their own home as it does not require laboratory processing. The test is designed for individuals with or without symptoms or other epidemiological reasons to suspect COVID-19 infection.
The pandemic was a boon to supermarket stocks as people ate more meals at home. Economic reopenings and inflation could spell trouble.